Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation

Current Biology

Volumn 7, Issue 11, 1997, Pages 817-826

  Liu, Kathleen D ^c   Gaffen, Sarah L ^c   Goldsmith, Mark A ^a,b   Greene, Warner C ^a,b  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; JANUS;

EID: 0031282551     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00369-1     Document Type: Article

References (51)

1. Gaffen SL, Goldsmith MA, Greene WC: Interleukin-2 and the interleukin-2 receptor complex. In The Cytokine Handbook. Edited by A. Thomson. London: Academic Press; 1997, in press.
2. Cosman D, Cerretti D, Larsen A, Park L, March C, Dower S, et al.: Cloning, sequence and expression of human interleukin-2 receptor. Nature 1984, 312:768-771.
3. Leonard WJ, Depper JM, Crabtree GR, Rudikoff S, Pumphrey J, Robb RJ, et al.: Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 1984, 311:626-631.
4. Nikaido T, Shimizu A, Ishida N, Sabe H, Teshigawara K, Maeda M, et al.: Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 1984, 311:631-635.
5. c chain. J Biol Chem 1995, 270:21729-21737.
6. Nelson BH, Lord JD, Greenberg PD: Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation. Nature 1994, 369:333-336.
7. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M, Francois C, et al.: Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling. Nature 1994, 369:330-333.
8. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 1990, 87:6934-6938.
9. Briscoe J, Guschin D, Rogers NC, Watling D, Muller M, Horn F, et al.: JAKs, STATs and signal transduction in response to the interferons and other cytokines. Philos Trans R Soc Lond (Biol): 1996, 351:167-171.
10. Darnell JE, Kerr IM, Stark GR: JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
11. Ihle JN: Cytokine receptor signaling. Nature 1995, 377:591-594.
12. Schindler C, Darnell JE: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 1995, 64:621-651.
13. c chains with JAK1 and JAK3: implications for XSCID and XCID. Science 1994, 266:1042-1045.
14. Beadling C, Gischin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, et al.: Activation of JAK kinases and STAT proteins by interleukin-2 and Interferon alpha, but not the T-cell antigen receptor, in human T lymphocytes. EMBO J 1994, 13:5605-5615.
15. Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA, et al.: Signaling through the IL-2R β chain activates a STAT-5-like DNA binding activity. Proc Natl Acad Sci USA 1995, 92:7192-7196.
16. Gilmour KC, Pine R, Reich NC: Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci USA 1995, 92:10772-10776.
17. Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL: Identification and purification of human STAT proteins activated in response to IL-2. Immunity 1995, 2:325-330.
18. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori H, Gouilleux F, et al.: Activation of STAT5 by interleukin 2 requires a carboxyl-terminal region of the interleukin-2 receptor β chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA 1995, 92:5482-5486.
19. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, et al.: Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 1995, 92:8705-8709.
20. Lin J-X, Migone T-S, Tsang M, Friedmann M, Weatherbee JA, Zhou L, et al.: The role of shared receptor motifs and common STAT proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 1995, 2:331-339.
21. Azam M, Erdjument-Bromage H, Kiedler BL, Xia M, Quelle F, Basu R, et al.: Interleukin-3 signals through multiple forms of STAT5. EMBO J 1995, 14:1402-1411.
22. Copeland NG, Gilbert DJ, Schindler C, Zhong Z, Wen Z, Darnell JE, et al.: Distribution of the mammalian STAT gene family in mouse chromosomes. Genomics 1995, 29:225-228.
23. Mui AL-F, Wakao H, O'Farrell A-M, Harada N, Miyajima A: Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J 1995, 14:1166-1175.
24. Gaffen SL, Lai SY, Ha M, Liu X, Hennighausen L, Greene WC, et al.: Distinct tyrosine residues within the interleukin-2 receptor β chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem 1996, 271:21381-21390.
25. Lin J-X, Mietz J, Modi WS, John S, Leonard WJ: Cloning of human STAT5B. J Biol Chem 1996, 271:10728-10744.
26. Liu KD, Lai SY, Goldsmith MA, Greene WC: Identification of a variable region within the cytoplasmic tail of the IL-2 receptor β chain that is required for growth signal transduction. J Biol Chem 1995, 270:22176-22181.
27. Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, et al.: Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor β-chain. Cytokine 1995, 7:689-700.
28. Briscoe J, Rogers NC, Witthuhn BA, Watling D, Harpur AG, Wilks AF, et al.: Kinase-negative mutants of JAK1 can sustain interferon-γ-inducible gene expression but not an antiviral state. EMBO J 1996, 15:799-809.
29. Morgan DO, De Bondt HL: Protein kinase regulation: insights from crystal structure analysis. Curr Opin Cell Biol 1994, 6:239-246.
30. Johnson LN, Noble MEM, Owen DJ: Active and inactive protein kinases: structural basis for regulation. Cell 1996, 85:149-158.
31. Hanks SK, Quinn AM, Hunter T: The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 1988, 241:42-52.
32. Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN: Activation of JAK2 catalytic activity requires phosphorylation of Y1007 in the kinase activation Loop. Mol Cell Biol 1997, 17:2497-2501.
33. Gauzzi MC, Velasquez L, McKendry R, Mogensen KE, Fellous M, Pellegrini S: Interferon-α-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem 1996, 271:20494-20500.
34. Gouilleux F, Wakao H, Mundt M, Groner B: Prolactin induces phosphorylation of Tyr694 of STAT5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 1994, 13:4361-4369.
35. Silvennoinen O, Ihle JN, Schlessinger J, Levy DE: Interferon-induced nuclear signalling by JAK protein tyrosine kinases. Nature 1993, 366:583-585.
36. Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S, Ihle JN: Phosphorylation and activation of the DNA binding activity of purified STAT1 by the Janus protein-kinases and the epidermal growth factor receptor. J Biol Chem 1995, 270:20775-20780.
37. Chen M, Cheng A, Chen Y-Q, Hymel A, Hanson EP, Kimmel L, et al.: The amino terminus of JAK3 is necessary and sufficient for binding to the common γ chain and confers the ability to transmit interleukin 2-mediated signals. Proc Natl Acad Sci USA 1997, 94:6910-6915.
38. Tanner JW, Chen W, Young RL, Longmore G, Shaw AS: The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 1995, 270:6523-6530.
39. Frank SJ, Yi W, Zhao Y, Goldsmith JF, Gilliland G, Jiang J, et al.: Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem 1995, 270:14776-14785.
40. Velazquez L, Mogensen KE, Barbieri G, Fellous M, Uze G, Pellegrini S: Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/ beta and for signal transduction. J Biol Chem 1995, 270:3327-3334.
41. Müller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, et al.: The protein tyrosine kinase JAK1 complements defects in interferon-alpha/ beta and -gamma signal transduction. Nature 1993, 366:129-166.
42. Park OK, Schaefer TS, Nathans D: In vitro activation of STAT3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci USA 1996, 93:13704-13708.
43. Rawlings DJ, Scharenberg AM, Park H, Wahl MI, Lin S, Kato RM, et al.: Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 1996, 271:822-825.
44. Hubbard SR, Wei L, Ellis L, Hendrickson WA: Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 1994, 372:746-754.
45. Mohammadi M, Schlessinger J, Hubbard SR: Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 1996, 86:577-587.
46. Goldsmith MA, Xu W, Amaral MC, Kuczek ES, Greene WC: The cytoplasmic domain of the IL-2 receptor β chain contains both unique and functionally redundant signal transduction elements. J Biol Chem 1994, 269:14698-14704.
47. Grussenmeyer T, Scheidtmann KH, Hutchinson MA, Eckhart W, Walter G: Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci USA 1985, 82:7952-7954.
48. rap1. Cell 1991, 65:1033-1042.
49. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989, 17:6419-6420.
50. Latchman DS: Transcription Factors: A Practical Approach. New York: IRL Press; 1993.
51. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1982.